New Milestone Towards Personalized Prevention of Type 1 Diabetes

Primary Oral Insulin Trial (POInT)
First Results Imply Personalized Strategies for the Future of Type 1 Diabetes

👉 Learn more: t1p.de/x3pq6
🔗 To the original publication: t1p.de/4x9qu

@tum.de @diabresearch-dzd.bsky.social
#typ1diabetes #prevention #GPPAD #OralInsulin #Insulin

Maternal Type 1 Diabetes May Protect Children Through Epigenetic Changes

Maternal Type 1 #Diabetes May Protect Children Through #Epigenetic Changes

A study from #HelmholtzMunich, #GPPAD & the TU Dresden University of Technology reveals that specific epigenetic modifications in the child’s DNA may underlie this protective effect.

👉 t1p.de/2emq1

@tudresden.bsky.social

Genetic Connection Between Newborn Blood Proteins and Type 1 Diabetes

Newborn Blood Proteins Linked to Type 1 Diabetes Risk🍼🔬

Researchers at #HelmholtzMunich have discovered a genetic link between certain blood proteins found in newborns and the future risk of developing #type1diabetes.

👉 t1p.de/ejo5r

@tum.de @natureportfolio.nature.com
#GPPAD #Biomarkers